Related Experiment Videos
Clinical experience with timolol in childhood glaucoma
Archives of Ophthalmology (Chicago, Ill. : 1960)
|August 1, 1985
Summary
Timolol maleate effectively treats pediatric glaucoma, reducing intraocular pressure in many children. Some patients achieved significant pressure reduction without further interventions, though potential complications should be monitored.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Pharmacology
Background:
- Childhood glaucoma is a serious condition requiring effective management.
- Timolol maleate is a commonly used beta-blocker for glaucoma treatment.
Purpose of the Study:
- To evaluate the efficacy of timolol maleate in treating pediatric glaucoma.
- To assess the long-term outcomes of timolol maleate monotherapy in children.
Main Methods:
- Retrospective study of 67 patients (100 eyes) with childhood glaucoma.
- Treatment with timolol maleate.
- Follow-up duration ranged from six to 60 months.
Main Results:
- Thirty patients (40 eyes) did not require additional surgery or medications.
- 78% of treated eyes showed a pressure drop.
- 45% of treated eyes experienced a pressure drop greater than 10 mm Hg.
Conclusions:
- Timolol maleate is an effective treatment for pediatric glaucoma.
- Long-term use can reduce the need for further interventions.
- Awareness of potential complications is necessary.